(1'S,2S,2'S,4S,4'S,7'R,8'R,9'S,11'S,12'S,13'S,15'R,16'S,18'S)-7',11',16'-trihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosane]-15'-yl acetate

ID: ALA508041

Chembl Id: CHEMBL508041

Cas Number: 66536-82-1

PubChem CID: 128330

Max Phase: Preclinical

Molecular Formula: C30H48O7

Molecular Weight: 520.71

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Epihippurin 1 | 22-epi-Hippurin-1|Epihippurin 1|66536-82-1|Hippurin|(22S)-1alpha-acetoxy-5alpha-furospirostan-3alpha,11beta,20R-triol|CHEMBL508041|DTXSID00985146|CHEBI:185496|BDBM50482556|LMST01090004|24-Methyl-22,25-epoxy-5alpha-furostan-2,3,11,20-tetrol 2-monoacetate|3,11,20-Trihydroxy-24-methyl-22,25-epoxyfurostan-2-yl acetate|[(1S,2S,3'S,4S,6S,7R,8R,9S,11S,12S,13S,15R,16S,18S)-7,11,16-trihydroxy-2',2',3',7,9,13-hexamethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,5'-oxolane]-15-Show More

Canonical SMILES:  CC(=O)O[C@@H]1C[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]3C[C@@H]3O[C@]4(C[C@H](C)C(C)(C)O4)[C@](C)(O)[C@@H]32)C[C@@H]1O

Standard InChI:  InChI=1S/C30H48O7/c1-15-12-30(37-26(15,3)4)29(7,34)25-22(36-30)11-19-18-9-8-17-10-20(32)23(35-16(2)31)14-27(17,5)24(18)21(33)13-28(19,25)6/h15,17-25,32-34H,8-14H2,1-7H3/t15-,17-,18-,19-,20-,21-,22-,23+,24+,25-,27-,28-,29+,30-/m0/s1

Standard InChI Key:  HRJBSUKSBJIMML-JQXFSTGHSA-N

Alternative Forms

  1. Parent:

    ALA508041

    EPIHIPPURIN 1

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Eif4a1 Eukaryotic initiation factor 4A-I (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 520.71Molecular Weight (Monoisotopic): 520.3400AlogP: 3.81#Rotatable Bonds: 1
Polar Surface Area: 105.45Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.83CX Basic pKa: CX LogP: 2.64CX LogD: 2.64
Aromatic Rings: Heavy Atoms: 37QED Weighted: 0.45Np Likeness Score: 3.15

References

1. Chao CH, Huang LF, Yang YL, Su JH, Wang GH, Chiang MY, Wu YC, Dai CF, Sheu JH..  (2005)  Polyoxygenated steroids from the gorgonian Isis hippuris.,  68  (6): [PMID:15974612] [10.1021/np050033y]
2. Bordeleau ME, Mori A, Oberer M, Lindqvist L, Chard LS, Higa T, Belsham GJ, Wagner G, Tanaka J, Pelletier J..  (2006)  Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A.,  (4): [PMID:16532013] [10.1038/nchembio776]

Source